We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Medical Properties (MPW) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
The latest trading session saw Medical Properties (MPW - Free Report) ending at $5.87, denoting a +0.86% adjustment from its last day's close. This change lagged the S&P 500's 2.13% gain on the day. On the other hand, the Dow registered a gain of 1.65%, and the technology-centric Nasdaq increased by 2.61%.
The health care real estate investment trust's stock has climbed by 20.25% in the past month, exceeding the Finance sector's loss of 6.68% and the S&P 500's loss of 9.57%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 37.5% drop compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $234.41 million, indicating a 13.6% decline compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.61 per share and revenue of $968.2 million. These totals would mark changes of -23.75% and -2.75%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.8% decrease. Currently, Medical Properties is carrying a Zacks Rank of #3 (Hold).
Looking at its valuation, Medical Properties is holding a Forward P/E ratio of 9.48. This expresses a discount compared to the average Forward P/E of 10.88 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 128, putting it in the top 50% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Medical Properties (MPW) Gains But Lags Market: What You Should Know
The latest trading session saw Medical Properties (MPW - Free Report) ending at $5.87, denoting a +0.86% adjustment from its last day's close. This change lagged the S&P 500's 2.13% gain on the day. On the other hand, the Dow registered a gain of 1.65%, and the technology-centric Nasdaq increased by 2.61%.
The health care real estate investment trust's stock has climbed by 20.25% in the past month, exceeding the Finance sector's loss of 6.68% and the S&P 500's loss of 9.57%.
Investors will be eagerly watching for the performance of Medical Properties in its upcoming earnings disclosure. The company's upcoming EPS is projected at $0.15, signifying a 37.5% drop compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $234.41 million, indicating a 13.6% decline compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.61 per share and revenue of $968.2 million. These totals would mark changes of -23.75% and -2.75%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for Medical Properties. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed a 0.8% decrease. Currently, Medical Properties is carrying a Zacks Rank of #3 (Hold).
Looking at its valuation, Medical Properties is holding a Forward P/E ratio of 9.48. This expresses a discount compared to the average Forward P/E of 10.88 of its industry.
The REIT and Equity Trust - Other industry is part of the Finance sector. This group has a Zacks Industry Rank of 128, putting it in the top 50% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.